XML 27 R13.htm IDEA: XBRL DOCUMENT v3.8.0.1
FAIR VALUE MEASUREMENTS
12 Months Ended
Mar. 31, 2018
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS
The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value. Level 1 refers to fair values determined based on quoted prices in active markets for identical assets. Level 2 refers to fair values estimated using significant other observable inputs, and Level 3 includes fair values estimated using significant non-observable inputs. The following tables present the Company’s financial assets and liabilities measured on a recurring basis using the fair value hierarchy at March 31, 2018 and 2017 (in thousands):
 
Fair Value Measurements at
 
March 31, 2018
 
Level 1
 
Level 2
 
Level 3
 
Total
ASSETS:
 
 
 
 
 
 
 
Cash and cash equivalents
$
369,821

 
$

 
$

 
$
369,821

U.S. government and municipal obligations
14,513

 
27,673

 

 
42,186

Commercial paper

 
33,003

 

 
33,003

Corporate bonds
2,752

 

 

 
2,752

Derivative financial instruments

 
122

 

 
122

 
$
387,086


$
60,798


$


$
447,884

LIABILITIES:
 
 
 
 
 
 
 
Contingent purchase consideration
$

 
$

 
$
(5,464
)
 
$
(5,464
)
Derivative financial instruments

 
(40
)
 

 
(40
)
 
$

 
$
(40
)
 
$
(5,464
)
 
$
(5,504
)
 
 
Fair Value Measurements at
 
March 31, 2017
 
Level 1
 
Level 2
 
Level 3
 
Total
ASSETS:
 
 
 
 
 
 
 
Cash and cash equivalents
$
304,880

 
$

 
$

 
$
304,880

U.S. government and municipal obligations
40,628

 
80,273

 

 
120,901

Commercial paper

 
29,469

 

 
29,469

Corporate bonds
7,956

 

 

 
7,956

Certificate of deposits

 
1,499

 

 
1,499

Derivative financial instruments

 
110

 

 
110

 
$
353,464

 
$
111,351

 
$

 
$
464,815

LIABILITIES:
 
 
 
 
 
 
 
Contingent purchase consideration
$

 
$

 
$
(5,449
)
 
$
(5,449
)
Derivative financial instruments

 
(213
)
 

 
(213
)
 
$

 
$
(213
)
 
$
(5,449
)
 
$
(5,662
)

 
This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. On a recurring basis, the Company measures certain financial assets and liabilities at fair value, including marketable securities and derivative financial instruments.
The Company’s Level 1 investments are classified as such because they are valued using quoted market prices or alternative pricing sources with reasonable levels of price transparency.
The Company’s Level 2 investments are classified as such because fair value is calculated using market observable data for similar but not identical instruments, or a discounted cash flow model using the contractual interest rate as compared to the underlying interest yield curve. The Company classifies municipal obligations as Level 2 because the fair values are determined using quoted prices from markets the Company considers to be inactive. Commercial paper is classified as Level 2 because the Company uses market information from similar but not identical instruments and discounted cash flow models based on interest rate yield curves to determine fair value. The Company's derivative financial instruments consist of forward foreign exchange contracts and are classified as Level 2 because the fair values of these derivatives are determined using models based on market observable inputs, including spot prices for foreign currencies and credit derivatives, as well as an interest rate factor.
The Company's Level 3 liabilities consist of contingent purchase consideration. The Company's contingent purchase consideration includes $523 thousand related to the acquisition of Efflux Systems, Inc. (Efflux) in the second quarter of fiscal year 2018. The contingent purchase consideration represents amounts deposited into an escrow account, which was established to cover damages NetScout might suffer related to any liabilities that NetScout did not agree to assume or as a result of the breach of representations and warranties of the seller as described in the merger agreement. The contingent purchase consideration is included as accrued other in the Company's consolidated balance sheet at March 31, 2018.
The Company's contingent purchase consideration at March 31, 2017 included $660 thousand related to the acquisition of certain assets and liabilities of Avvasi Inc. (Avvasi) in the second quarter of fiscal year 2017. The contingent purchase consideration represented amounts deposited into an escrow account, which was established to cover damages the Company suffers related to any liabilities that the Company did not agree to assume or as a result of the breach of representations and warranties of the seller as described in the merger agreement. The contingent purchase consideration was paid to the seller in August 2017.
The fair value of contingent purchase consideration related to the acquisition of Simena LLC (Simena) in November 2011 for future consideration to be paid to the former seller is $4.9 million and $4.8 million at March 31, 2018 and 2017, respectively. The contingent purchase consideration is included as a contingent liability within accrued other in the Company's consolidated balance sheet at March 31, 2018 and as a long-term contingent liability at March 31, 2017.
The following table sets forth a reconciliation of changes in the fair value of the Company’s Level 3 financial liabilities for the year ended March 31, 2018 (in thousands):
 
Contingent
Purchase
Consideration
Balance at March 31, 2017
$
(5,449
)
Additions to Level 3
(523
)
Increase in fair value and accretion expense (included within research and development expense)
(152
)
Payments made
660

Balance at March 31, 2018
$
(5,464
)

Deal-related compensation expense and accretion charges related to the contingent purchase consideration for the fiscal year ended March 31, 2018 were $152 thousand and were included as part of earnings.
The following table sets forth a reconciliation of changes in the fair value of the Company’s Level 3 financial liabilities for the year ended March 31, 2017 (in thousands):
 
Contingent
Purchase
Consideration
 
Contingently Returnable Consideration
Balance at March 31, 2016
$
(7,293
)
 
$
16,131

Additions to Level 3
(660
)
 

Increase in fair value and accretion expense (included within research and development expense)
(153
)
 

Decrease in fair value

 
(610
)
Gross presentation of contingently returnable consideration to contingent purchase consideration
(3,910
)
 
3,910

Payments received

 
(19,431
)
Payments made
6,567

 

Balance at March 31, 2017
$
(5,449
)
 
$


Deal related compensation expense, accretion charges and changes related to settlements of contractual non-compliance liabilities for the fiscal year ended March 31, 2017 were $153 thousand and were included as part of earnings.